Valuation Update With 7 Day Price Move • May 20
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to S$1.36, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 17x in the Chemicals industry in Asia. Total loss to shareholders of 3.4% over the past three years. Board Change • May 02
High number of new directors Independent Non-Executive Director Swee Ho Tan was the last director to join the board, commencing their role in the last week. Valuation Update With 7 Day Price Move • Apr 28
Investor sentiment improves as stock rises 44% After last week's 44% share price gain to S$1.36, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 18x in the Chemicals industry in Asia. Total loss to shareholders of 9.0% over the past three years. Major Estimate Revision • Apr 25
Consensus EPS estimates increase by 36% The consensus outlook for earnings per share (EPS) in fiscal year 2026 has improved. 2026 revenue forecast increased from S$268.7m to S$284.2m. EPS estimate increased from S$0.027 to S$0.037 per share. Net income forecast to grow 104% next year vs 32% growth forecast for Chemicals industry in Singapore. Consensus price target up from S$0.75 to S$1.65. Share price rose 79% to S$1.54 over the past week. New Risk • Apr 21
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Singaporean stocks, typically moving 9.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Board Change • Apr 21
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 1 highly experienced director. Independent Director Steve G. Ghanayem was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Tillkännagivande • Apr 15
Nanofilm Technologies International Limited Announces Retirement of Steve Ghanayem as Independent and Non-Executive Director Member of the Nominating Committee Member of the Remuneration Committee Nanofilm Technologies International Limited announced cessation of Steve Ghanayem as Independent and Non-Executive Director Member of the Nominating Committee Member of the Remuneration Committee. Other DirectorShips Present: 1. President (US Operations) and Head of Global Sales at Tata Electronics Private Limited 2. Owner and shareholder of Ghanayem Consulting, LLC. Reason For Cessation: Mr. Steve Ghanayem is due to retire at the Company's forthcoming Annual General Meeting on 29 April 2026 and is eligible for re-election. Mr. Ghanayem has decided not to seek re-election due to his other professional commitment. Following Mr. Ghanayem's resignation as Non-Executive Independent Director, he will also step down as member of the Nominating Committee and member of the Remuneration Committee. Tillkännagivande • Feb 26
Nanofilm Technologies International Limited, Annual General Meeting, Apr 29, 2026 Nanofilm Technologies International Limited, Annual General Meeting, Apr 29, 2026. Tillkännagivande • Jan 21
Nanofilm Technologies International Limited Announces Striking-Off of Dormant Subsidiary The Board of Directors of Nanofilm Technologies International Limited announced that Nanofilm Ventures Pte. Ltd. ("Nanofilm Ventures"), an indirect wholly-owned subsidiary of the Company, had been struck off the Register of Companies with effect from 10 January 2026 pursuant to an application submitted to the Accounting and Corporate Regulatory Authority under Section 344A of the Companies Act 1967 of Singapore. Nanofilm Ventures was dormant prior to the striking-off application. The striking-off of this dormant subsidiary is not expected to have any material effect on the consolidated earnings per share and the net tangible asset value per share of the Company for the financial year ending 31 December 2026. Board Change • Dec 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 1 highly experienced director. Independent Director Steve G. Ghanayem was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Price Target Changed • Nov 26
Price target increased by 23% to S$0.63 Up from S$0.51, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of S$0.66. Stock is down 16% over the past year. The company is forecast to post earnings per share of S$0.016 for next year compared to S$0.012 last year. Major Estimate Revision • Aug 20
Consensus EPS estimates fall by 18% The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from S$0.02 to S$0.016 per share. Revenue forecast steady at S$229.2m. Net income forecast to grow 0.8% next year vs 31% growth forecast for Chemicals industry in Singapore. Consensus price target up from S$0.51 to S$0.62. Share price fell 6.6% to S$0.70 over the past week. Reported Earnings • Aug 15
First half 2025 earnings released: EPS: S$0.002 (vs S$0.006 loss in 1H 2024) First half 2025 results: EPS: S$0.002 (up from S$0.006 loss in 1H 2024). Revenue: S$107.2m (up 30% from 1H 2024). Net income: S$1.61m (up S$5.35m from 1H 2024). Profit margin: 1.5% (up from net loss in 1H 2024). The move to profitability was driven by higher revenue. Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Chemicals industry in Asia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 46 percentage points per year, which is a significant difference in performance. Declared Dividend • Aug 15
First half dividend of S$0.0033 announced Dividend of S$0.0033 is the same as last year. Ex-date: 28th August 2025 Payment date: 5th September 2025 Dividend yield will be 0.9%, which is lower than the industry average of 7.1%. Price Target Changed • Jun 23
Price target decreased by 10% to S$0.53 Down from S$0.59, the current price target is an average from 5 analysts. New target price is 15% below last closing price of S$0.63. Stock is down 13% over the past year. The company is forecast to post earnings per share of S$0.022 for next year compared to S$0.012 last year. Price Target Changed • Apr 25
Price target decreased by 10% to S$0.59 Down from S$0.66, the current price target is an average from 6 analysts. New target price is 8.4% above last closing price of S$0.55. Stock is down 16% over the past year. The company is forecast to post earnings per share of S$0.025 for next year compared to S$0.012 last year. Reported Earnings • Apr 12
Full year 2024 earnings: EPS misses analyst expectations Full year 2024 results: EPS: S$0.012 (up from S$0.005 in FY 2023). Revenue: S$204.3m (up 15% from FY 2023). Net income: S$7.74m (up 147% from FY 2023). Profit margin: 3.8% (up from 1.8% in FY 2023). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 48%. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Chemicals industry in Asia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 38 percentage points per year, which is a significant difference in performance. Tillkännagivande • Apr 10
Nanofilm Technologies International Limited Announces Board and Committee Changes The Board of Directors of Nanofilm Technologies International Limited announced the retirement of Mr. Kristian John Robinson as Non-Executive Independent Director, Chairman of the Nominating Committee and Member of the Remuneration Committee of the Company, with effect from 25 April 2025. The Board and Management would like to express their sincere appreciation to Mr. Robinson for his valuable contributions and guidance to the Board and the Company during his tenure as Director of the Company. In light of the above, the Board wishes to announce the following changes made to the composition of the Nominating Committee ("NC") and the Remuneration Committee ("RC"), effective 25 April 2025: Ms. Ong Siew Koon @ Ong Siew Khoon, Lead Independent Director and currently a member of the NC, has been redesignated as Chairman of the NC. Ms Ong remains as Chairman of the Audit Committee ("AC") and a member of the Board Risk Committee ("BRC"). Mr. Steve Ghanayem, Independent Director, has been appointed as a member of the NC. Mr. Ghanayem remains as a member of the BRC and the RC. Mr. Wan Kum Tho, Independent Director, has been appointed as a member of the RC. Mr. Wan remains as Chairman of the BRC and a member of the AC and NC. The Board and Board Committees are re-constituted as set out below. Dr Shi Xu Mr. Wan Kum Tho (Independent Director), (Executive Chairman and Chief Executive Officer) Ms Lee Lee Khoon (Independent Director), Ms Ong Siew Koon @ Ong Siew Khoon Mr. Steve Ghanayem (Independent Director), Audit Committee: Ms. Ong Siew Koon @ Ong Siew Khoon (Chairman), Mr. Wan Kum Tho (Chairman), Ms Lee Lee Khoon (Member), Ms. Lee Lee Khoon (Member), Mr. Wan Kum Tho (Member). Board Risk Committee is Mr. Wan Kum Tho (Chairman), Mr. Wan Kum Tho (Chairman), Mr. Steve Ghanayem (Member). Nominating Committee is Ms. Ong Siew Koon @ Ong Siew Khoon (Chairman), Mr. Wan Kum Tho (Member) and Mr. Steve Ghanayem (Member). Remuneration Committee: Ms. Lee Lee Khoon (Chairman), Mr. Steve Ghanayem (Member), and Mr. Wan Kum Tho (Member). New Risk • Mar 02
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 36% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. This is currently the only risk that has been identified for the company. Price Target Changed • Feb 27
Price target decreased by 7.4% to S$0.66 Down from S$0.71, the current price target is an average from 6 analysts. New target price is 6.1% below last closing price of S$0.70. Stock is down 0.7% over the past year. The company is forecast to post earnings per share of S$0.032 for next year compared to S$0.012 last year. Reported Earnings • Feb 26
Full year 2024 earnings: EPS misses analyst expectations Full year 2024 results: EPS: S$0.012 (up from S$0.005 in FY 2023). Revenue: S$204.3m (up 15% from FY 2023). Net income: S$7.74m (up 147% from FY 2023). Profit margin: 3.8% (up from 1.8% in FY 2023). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 48%. Revenue is forecast to grow 15% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in Asia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 45 percentage points per year, which is a significant difference in performance. Tillkännagivande • Feb 26
Nanofilm Technologies International Limited, Annual General Meeting, Apr 25, 2025 Nanofilm Technologies International Limited, Annual General Meeting, Apr 25, 2025. Major Estimate Revision • Dec 03
Consensus EPS estimates fall by 12% The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate fell from S$0.024 to S$0.021. Revenue forecast unchanged from S$205.5m at last update. Net income forecast to grow 188% next year vs 35% growth forecast for Chemicals industry in Singapore. Consensus price target of S$0.72 unchanged from last update. Share price was steady at S$0.80 over the past week. Price Target Changed • Oct 31
Price target increased by 8.1% to S$0.69 Up from S$0.64, the current price target is an average from 6 analysts. New target price is 16% below last closing price of S$0.82. Stock is down 13% over the past year. The company is forecast to post earnings per share of S$0.024 for next year compared to S$0.0048 last year. Board Change • Oct 04
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 1 highly experienced director. Independent Director Steve G. Ghanayem was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Major Estimate Revision • Aug 20
Consensus EPS estimates fall by 20%, revenue upgraded The consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from S$204.4m to S$207.2m. EPS estimate fell from S$0.034 to S$0.027 per share. Net income forecast to grow 216% next year vs 34% growth forecast for Chemicals industry in Singapore. Consensus price target broadly unchanged at S$0.68. Share price fell 10% to S$0.70 over the past week. Reported Earnings • Aug 17
First half 2024 earnings released: S$0.006 loss per share (vs S$0.012 loss in 1H 2023) First half 2024 results: S$0.006 loss per share (improved from S$0.012 loss in 1H 2023). Revenue: S$82.6m (up 13% from 1H 2023). Net loss: S$3.74m (loss narrowed 51% from 1H 2023). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Chemicals industry in Asia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 22 percentage points per year, which is a significant difference in performance. Declared Dividend • Aug 15
First half dividend of S$0.0033 announced Dividend of S$0.0033 is the same as last year. Ex-date: 29th August 2024 Payment date: 6th September 2024 Dividend yield will be 0.9%, which is lower than the industry average of 7.1%. Tillkännagivande • Jul 10
Nanofilm Technologies International Limited Announces Change of Company Secretary Nanofilm Technologies International Limited announced the appointment of Mr. Cho Form Po as joint Company Secretary of the Company with effect from 10 July 2024, in place of Ms. Zhan Aijuan who has resigned with effect from 10 July 2024. Tillkännagivande • Apr 27
Nanofilm Technologies International Limited Declares Final Tax-Exempt One Tier Dividend for the Financial Year Ended 31 December 2023 Nanofilm Technologies International Limited announced at its AGM held on 26 April 2024 Declaration of final dividend (tax exempt one-tier) of SGD 0.0033 per ordinary share for the financial year ended 31 December 2023. Reported Earnings • Apr 16
Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2023 results: EPS: S$0.005 (down from S$0.067 in FY 2022). Revenue: S$177.0m (down 25% from FY 2022). Net income: S$3.14m (down 93% from FY 2022). Profit margin: 1.8% (down from 19% in FY 2022). The decrease in margin was driven by lower revenue. Revenue exceeded analyst estimates by 3.5%. Earnings per share (EPS) missed analyst estimates by 57%. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Chemicals industry in Asia. Over the last 3 years on average, earnings per share has fallen by 47% per year whereas the company’s share price has fallen by 51% per year. Major Estimate Revision • Mar 04
Consensus revenue estimates fall by 13% The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from S$233.9m to S$204.5m. EPS estimate fell from S$0.052 to S$0.034 per share. Net income forecast to grow 612% next year vs 39% growth forecast for Chemicals industry in Singapore. Consensus price target down from S$0.85 to S$0.74. Share price was steady at S$0.73 over the past week. Price Target Changed • Feb 28
Price target decreased by 12% to S$0.75 Down from S$0.85, the current price target is an average from 7 analysts. New target price is approximately in line with last closing price of S$0.71. Stock is down 52% over the past year. The company is forecast to post earnings per share of S$0.034 for next year compared to S$0.0048 last year. Major Estimate Revision • Nov 09
Consensus EPS estimates increase by 11%, revenue downgraded The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from S$190.7m to S$178.5m. EPS estimate rose from S$0.02 to S$0.022. Net income forecast to grow 48% next year vs 39% growth forecast for Chemicals industry in Singapore. Consensus price target down from S$1.04 to S$0.95. Share price fell 7.4% to S$0.88 over the past week. Price Target Changed • Aug 16
Price target decreased by 9.5% to S$1.07 Down from S$1.18, the current price target is an average from 8 analysts. New target price is approximately in line with last closing price of S$1.03. Stock is down 56% over the past year. The company is forecast to post earnings per share of S$0.02 for next year compared to S$0.067 last year. Major Estimate Revision • Aug 14
Consensus EPS estimates fall by 13% The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate fell from S$0.053 to S$0.046. Revenue forecast unchanged from S$215.4m at last update. Net income forecast to shrink 37% next year vs 32% growth forecast for Chemicals industry in Singapore . Consensus price target down from S$1.18 to S$1.10. Share price fell 2.9% to S$1.02 over the past week. Tillkännagivande • Aug 12
Nanofilm Technologies International Limited Announces Appointment of Zhan Aijuan as Joint Company Secretary The Board of Directors of Nanofilm Technologies International Limited announced that Ms. Zhan Aijuan will be appointed as joint Company Secretary of the Company with effect from 11 August 2023. Consequential to the aforesaid change, the joint Company Secretaries of the Company are Ms. Eunice Hooi and Ms. Zhan Aijuan. Tillkännagivande • Aug 11
Nanofilm Technologies International Limited Declares Tax-Exempt One Tier Interim Dividend for the Financial Year Ending 31 December 2023, Payable on 8 September 2023 Nanofilm Technologies International Limited declared a tax-exempt one tier interim dividend of SGD 0.0033 per ordinary share for the financial year ending 31 December 2023. The Share Transfer Books and Register of Members of the Company will be closed on 30 August 2023 (Record Date) for the purpose of determining shareholders' entitlements to the Interim Dividend. Dividend payment date: 8 September 2023. Tillkännagivande • Jul 12
Nanofilm Technologies International Limited Provides Earnings Guidance for the First Half and Second Half of 2023 The Board of Directors of Nanofilm Technologies International Limited provided an update on the financial performance of the Group for the six-months ended 30 June 2023 and the outlook for the financial year ending 31 December 2023. Based on a preliminary assessment of the information currently available to the Board, including the Group's management accounts (which have not undergone review by the audit committee or external auditors of the Company), it is anticipated that the Group will report a revenue decline of approximately 34% to SGD 73 million and a net loss of approximately SGD 8 million for 1H2023, as compared to the six-months ended 30 June 2022. The Group will continue to recognise a positive Earnings before Interest, Taxes, Depreciation and Amortisation for 1H2023. Looking ahead to the second half of the year, considering these initiatives and based on currently available information and barring any unforeseen circumstances, the Group expects: revenue for the second half of FY2023 to be higher than 1H2023; and the Group to be profitable for FY2023. Valuation Update With 7 Day Price Move • Jul 11
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to S$1.13, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 14x in the Chemicals industry in Asia. Total loss to shareholders of 49% over the past year. Simply Wall St's valuation model estimates the intrinsic value at S$2.00 per share. Valuation Update With 7 Day Price Move • Jun 26
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to S$1.35, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 14x in the Chemicals industry in Asia. Total loss to shareholders of 44% over the past year. Simply Wall St's valuation model estimates the intrinsic value at S$1.86 per share. Major Estimate Revision • Jun 23
Consensus EPS estimates fall by 17% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from S$239.7m to S$227.5m. EPS estimate also fell from S$0.068 per share to S$0.056 per share. Net income forecast to shrink 9.4% next year vs 30% growth forecast for Chemicals industry in Singapore . Consensus price target down from S$1.34 to S$1.24. Share price fell 15% to S$1.38 over the past week. Price Target Changed • Jun 23
Price target decreased by 7.2% to S$1.24 Down from S$1.34, the current price target is an average from 8 analysts. New target price is 10.0% below last closing price of S$1.38. Stock is down 44% over the past year. The company is forecast to post earnings per share of S$0.063 for next year compared to S$0.067 last year. Buying Opportunity • Jun 22
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 3.9%. The fair value is estimated to be S$1.86, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years, while earnings per share has been flat. For the next 3 years, revenue is forecast to grow by 17% per annum. Earnings is also forecast to grow by 21% per annum over the same time period. Upcoming Dividend • May 02
Upcoming dividend of S$0.011 per share at 1.5% yield Eligible shareholders must have bought the stock before 08 May 2023. Payment date: 18 May 2023. Payout ratio is a comfortable 33% but the company is paying out more than the cash it is generating. Trailing yield: 1.5%. Lower than top quartile of Singaporean dividend payers (6.4%). Lower than average of industry peers (3.6%). Major Estimate Revision • Apr 21
Consensus EPS estimates fall by 11% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from S$265.6m to S$255.7m. EPS estimate also fell from S$0.078 per share to S$0.07 per share. Net income forecast to grow 6.1% next year vs 21% growth forecast for Chemicals industry in Singapore. Consensus price target down from S$1.40 to S$1.33. Share price fell 11% to S$1.51 over the past week. Reported Earnings • Apr 14
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: EPS: S$0.067 (down from S$0.094 in FY 2021). Revenue: S$237.4m (down 3.8% from FY 2021). Net income: S$43.8m (down 30% from FY 2021). Profit margin: 19% (down from 25% in FY 2021). The decrease in margin was primarily driven by higher expenses. Revenue missed analyst estimates by 9.5%. Earnings per share (EPS) also missed analyst estimates by 17%. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Chemicals industry in Asia. Price Target Changed • Feb 23
Price target decreased by 8.1% to S$1.55 Down from S$1.69, the current price target is an average from 8 analysts. New target price is 7.1% above last closing price of S$1.45. Stock is down 48% over the past year. The company is forecast to post earnings per share of S$0.082 for next year compared to S$0.067 last year. Reported Earnings • Feb 22
Full year 2022 earnings: Revenues miss analyst expectations Full year 2022 results: Revenue: S$237.4m (down 3.8% from FY 2021). Net income: S$43.8m (down 30% from FY 2021). Profit margin: 19% (down from 25% in FY 2021). The decrease in margin was primarily driven by higher expenses. Revenue missed analyst estimates by 9.5%. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in Asia. Tillkännagivande • Feb 03
Nanofilm Technologies International Limited Provides Earnings Guidance for the Year Ended 31 December 2022 Nanofilm Technologies International Limited provided earnings guidance for the year ended 31 December 2022. For the period, the company is expected to report a decrease in revenue of approximately 4% for FY2022 ("Revenue") and a decrease in net profit after tax and minority interest of approximately 30% for FY2022 ("PATMI"), as compared to the financial year ended 31 December 2021. Tillkännagivande • Jan 13
Nanofilm Technologies International Limited Announces Change of Company Secretaries The Board of Directors of Nanofilm Technologies International Limited announced the appointment of Ms. Eunice Hooi as Company Secretary ofthe Company with effect from 12 January 2023, in place of Mr. Chester Leong and Ms. Josephine Toh, the joint Company Secretaries, who have resigned with effect from 12 January 2023. Valuation Update With 7 Day Price Move • Dec 05
Investor sentiment improved over the past week After last week's 16% share price gain to S$1.49, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 13x in the Chemicals industry in Asia. Total loss to shareholders of 62% over the past year. Price Target Changed • Nov 18
Price target decreased to S$1.90 Down from S$2.14, the current price target is an average from 8 analysts. New target price is 45% above last closing price of S$1.31. Stock is down 68% over the past year. The company is forecast to post earnings per share of S$0.093 for next year compared to S$0.094 last year. Board Change • Nov 16
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. 1 highly experienced director. Founder & Executive Chairman Xu Shi is the most experienced director on the board, commencing their role in 1999. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Valuation Update With 7 Day Price Move • Nov 04
Investor sentiment deteriorated over the past week After last week's 17% share price decline to S$1.46, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 12x in the Chemicals industry in Asia. Total loss to shareholders of 61% over the past year. Tillkännagivande • Oct 13
Nanofilm Technologies International Limited Appoints Steve Ghanayem as Independent Director Nanofilm Technologies International Limited considered the Nominating Committee's recommendation and assessment of the qualifications, experience and independence of Mr. Steve Ghanayem and is of the view that Mr. Ghanayem is suitable for the role of Independent and Non-Executive Director Member of the Board Risk Committee of the Company. The Board is also of the view that Mr. Ghanayem's skills, knowledge, and experience will enhance the core competencies of the Board. The Board notes that Mr. Ghanayem is a shareholder and owner of Ghanayem Consulting, LLC. He holds Bachelor of Science in Chemical Engineering, 1988 University of California Berkeley. Upcoming Dividend • Aug 24
Upcoming dividend of S$0.011 per share Eligible shareholders must have bought the stock before 31 August 2022. Payment date: 09 September 2022. Payout ratio is a comfortable 22% but the company is not cash flow positive. Trailing yield: 0.9%. Lower than top quartile of Singaporean dividend payers (6.0%). Lower than average of industry peers (1.9%). Reported Earnings • Aug 16
First half 2022 earnings released: EPS: S$0.029 (vs S$0.027 in 1H 2021) First half 2022 results: EPS: S$0.029 (up from S$0.027 in 1H 2021). Revenue: S$111.3m (up 15% from 1H 2021). Net income: S$18.8m (up 5.1% from 1H 2021). Profit margin: 17% (down from 19% in 1H 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 24%, compared to a 24% growth forecast for the Chemicals industry in Singapore. Price Target Changed • Aug 15
Price target decreased to S$2.83 Down from S$3.08, the current price target is an average from 9 analysts. New target price is 25% above last closing price of S$2.26. Stock is down 47% over the past year. The company is forecast to post earnings per share of S$0.11 for next year compared to S$0.094 last year. Tillkännagivande • Aug 12
Nanofilm Technologies International Limited Declares One Tier Interim Dividend for the Financial Year Ending 31 December 2022, Payable on 9 September 2022 Nanofilm Technologies International Limited declares one tier interim dividend of SGD 0.011 per ordinary share for the financial year ending 31 December 2022. Record Date is 1 September 2022 and Dividend Payment Date 9 September 2022. Recent Insider Transactions Derivative • Jul 09
Group CEO & Executive Director exercised options to buy S$3.8m worth of stock. On the 8th of July, Hock Yong Ho exercised options to buy 2m shares at a strike price of around S$0.59, costing a total of S$1.0m. This transaction amounted to 131% of their direct individual holding at the time of the trade. Since September 2021, Hock Yong has owned 1.30m shares directly. Company insiders have collectively bought S$1.1m more than they sold, via options and on-market transactions, in the last 12 months. Price Target Changed • Jun 29
Price target decreased to S$3.24 Down from S$3.51, the current price target is an average from 9 analysts. New target price is 37% above last closing price of S$2.37. Stock is down 57% over the past year. The company is forecast to post earnings per share of S$0.12 for next year compared to S$0.094 last year. Tillkännagivande • Jun 09
Nanofilm Technologies International Limited Announces Resignation of Sean Tan Chee Kwong as Chief Human Resources Officer Nanofilm Technologies International Limited announced Sean Tan Chee Kwong resigned due to personal reasons. He will continue to serve as human resources (HR) consultant to the Group following the last day of his employment with the Company. Role And Responsibilities: Responsible for developing and executing HR strategy and overseeing the overall HR function of the Group. Upcoming Dividend • May 02
Upcoming dividend of S$0.01 per share Eligible shareholders must have bought the stock before 09 May 2022. Payment date: 20 May 2022. Payout ratio is a comfortable 21% but the company is not cash flow positive. Trailing yield: 0.7%. Lower than top quartile of Singaporean dividend payers (5.8%). Lower than average of industry peers (1.4%). Board Change • Apr 27
High number of new and inexperienced directors There are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. 1 highly experienced director. Founder & Executive Chairman Xu Shi is the most experienced director on the board, commencing their role in 1999. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Apr 14
Full year 2021 earnings: EPS and revenues miss analyst expectations Full year 2021 results: EPS: S$0.094. Revenue: S$246.7m (up 13% from FY 2020). Net income: S$62.2m (up 8.0% from FY 2020). Profit margin: 25% (down from 26% in FY 2020). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 8.3%. Earnings per share (EPS) also missed analyst estimates by 3.3%. Over the next year, revenue is forecast to grow 26%, compared to a 29% growth forecast for the industry in Singapore. 
